CDC recommends Moderna and Pfizer COVID-19 vaccines over J&J
The U.S. Centers for Disease Control and Prevention (CDC) endorses the updated recommendations by its Advisory Committee on Immunization Practices (ACIP) expressing a clinical preference for individuals to receive an mRNA COVID-19 vaccine manufactured by Pfizer/BioNTech and Moderna over the Janssen (Johnson & Johnson) COVID-19 vaccine.
The new CDC recommendation states, “mRNA vaccines are preferred over the Janssen COVID-19 vaccine for the prevention of COVID-19 for those 18 years of age and over.”
On December 16, CDC Director Dr. Rochelle Walensky said, “We have made important strides in the year since the COVID-19 vaccination program started. More than 200 million Americans have completed their primary vaccine series, providing protection against COVID-19, preventing millions of cases and hospitalizations, and saving over a million lives. Today’s updated recommendation emphasizes CDC’s commitment to provide real-time scientific information to the American public. I continue to encourage all Americans to get vaccinated and boosted.”
ACIP did not recommend removing the Janssen COVID-19 as an option in the U.S. for people who prefer the one-dose vaccination.
CDC’s recommendation was made after reviewing the benefits and risks of the Janssen COVID-19 vaccine.
acadianavaccinefinder.com 